Autoinhibition Mechanism of the Ubiquitin-Conjugating Enzyme UBE2S by Autoubiquitination.


Journal

Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697

Informations de publication

Date de publication:
06 08 2019
Historique:
received: 08 03 2019
revised: 01 05 2019
accepted: 17 05 2019
pubmed: 25 6 2019
medline: 8 5 2020
entrez: 25 6 2019
Statut: ppublish

Résumé

Ubiquitin-conjugating enzymes (E2s) govern key aspects of ubiquitin signaling. Emerging evidence suggests that the activities of E2s are modulated by posttranslational modifications; the structural underpinnings, however, are largely unclear. Here, we unravel the structural basis and mechanistic consequences of a conserved autoubiquitination event near the catalytic center of E2s, using the human anaphase-promoting complex/cyclosome-associated UBE2S as a model system. Crystal structures we determined of the catalytic ubiquitin carrier protein domain combined with MD simulations reveal that the active-site region is malleable, which permits an adjacent ubiquitin acceptor site, Lys

Identifiants

pubmed: 31230944
pii: S0969-2126(19)30170-4
doi: 10.1016/j.str.2019.05.008
pii:
doi:

Substances chimiques

Ubiquitin 0
Ube2S protein, human EC 2.3.2.23
Ubiquitin-Conjugating Enzymes EC 2.3.2.23
Lysine K3Z4F929H6
Cysteine K848JZ4886

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1195-1210.e7

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Anna K L Liess (AKL)

Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, 97080 Würzburg, Germany.

Alena Kucerova (A)

Cell Cycle, Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Kristian Schweimer (K)

Biopolymers, University of Bayreuth, 95447 Bayreuth, Germany.

Lu Yu (L)

Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK.

Theodoros I Roumeliotis (TI)

Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK.

Mathias Diebold (M)

Institute of Pharmacy and Food Chemistry, University of Würzburg, 97074 Würzburg, Germany.

Olexandr Dybkov (O)

Department for Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry, Göttingen, 37077 Göttingen, Germany.

Christoph Sotriffer (C)

Institute of Pharmacy and Food Chemistry, University of Würzburg, 97074 Würzburg, Germany.

Henning Urlaub (H)

Group for Bioanalytical Mass Spectrometry, Max Planck Institute for Biophysical Chemistry, Göttingen, 37077 Göttingen, Germany; Proteomics Service Facility, Georg-August-Universität, Göttingen, 37077 Göttingen, Germany.

Jyoti S Choudhary (JS)

Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK.

Jörg Mansfeld (J)

Cell Cycle, Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany. Electronic address: joerg.mansfeld@tu-dresden.de.

Sonja Lorenz (S)

Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, 97080 Würzburg, Germany. Electronic address: sonja.lorenz@virchow.uni-wuerzburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH